nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo
|
Roghanian, Ali |
|
2015 |
27 |
4 |
p. 473-488 16 p. |
artikel |
2 |
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
|
Elkabets, Moshe |
|
2015 |
27 |
4 |
p. 533-546 14 p. |
artikel |
3 |
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
|
von Karstedt, Silvia |
|
2015 |
27 |
4 |
p. 561-573 13 p. |
artikel |
4 |
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
|
Crescenzo, Ramona |
|
2015 |
27 |
4 |
p. 516-532 17 p. |
artikel |
5 |
Designed to Kill: Novel Menin-MLL Inhibitors Target MLL-Rearranged Leukemia
|
Kühn, Michael W.M. |
|
2015 |
27 |
4 |
p. 431-433 3 p. |
artikel |
6 |
FAK to the Rescue: Activated Stroma Promotes a “Safe Haven” for BRAF-Mutant Melanoma Cells by Inducing FAK Signaling
|
Frame, Margaret C. |
|
2015 |
27 |
4 |
p. 429-431 3 p. |
artikel |
7 |
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
|
Topalian, Suzanne L. |
|
2015 |
27 |
4 |
p. 450-461 12 p. |
artikel |
8 |
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
|
Hirata, Eishu |
|
2015 |
27 |
4 |
p. 574-588 15 p. |
artikel |
9 |
Macrophages and Therapeutic Resistance in Cancer
|
Ruffell, Brian |
|
2015 |
27 |
4 |
p. 462-472 11 p. |
artikel |
10 |
Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
|
Shih, Alan H. |
|
2015 |
27 |
4 |
p. 502-515 14 p. |
artikel |
11 |
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
|
Woll, Petter S. |
|
2015 |
27 |
4 |
p. 603-605 3 p. |
artikel |
12 |
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
|
Borkin, Dmitry |
|
2015 |
27 |
4 |
p. 589-602 14 p. |
artikel |
13 |
Radiotherapy Complements Immune Checkpoint Blockade
|
Ngiow, Shin Foong |
|
2015 |
27 |
4 |
p. 437-438 2 p. |
artikel |
14 |
Releasing the Brakes: Targeting FcγRIIB on B Cells to Enhance Antibody-Dependent Lymphoma Immunotherapy
|
Seeling, Michaela |
|
2015 |
27 |
4 |
p. 427-428 2 p. |
artikel |
15 |
Something in the Air: Hyperoxic Conditioning of the Tumor Microenvironment for Enhanced Immunotherapy
|
Leone, Robert D. |
|
2015 |
27 |
4 |
p. 435-436 2 p. |
artikel |
16 |
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
|
Zhu, Eric F. |
|
2015 |
27 |
4 |
p. 489-501 13 p. |
artikel |
17 |
TGIF Governs a Feed-Forward Network that Empowers Wnt Signaling to Drive Mammary Tumorigenesis
|
Zhang, Ming-Zhu |
|
2015 |
27 |
4 |
p. 547-560 14 p. |
artikel |
18 |
The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy
|
Miller, Jacques F.A.P. |
|
2015 |
27 |
4 |
p. 439-449 11 p. |
artikel |
19 |
When One Mutation Is All It Takes
|
Greaves, Mel |
|
2015 |
27 |
4 |
p. 433-434 2 p. |
artikel |